Alliance for Cancer Gene Therapy Awards Grant for Brain Cancer Research Project

Blog
Article

ACGT recently awarded a half-million dollar grant to brain cancer researcher Juan Fueyo, MD, who is developing an oncolytic virus therapy to treat the brain cancer glioblastoma.

Juan Fueyo, MD, of The University of Texas MD Anderson Cancer Center

Juan Fueyo, MD, of The University of Texas MD Anderson Cancer Center

Alliance for Cancer Gene Therapy (ACGT) recently awarded a $500,000 grant to brain cancer researcher Juan Fueyo, MD, of The University of Texas MD Anderson Cancer Center. He is developing an oncolytic virus therapy to treat the brain cancer glioblastoma.

The oncolytic virus has already been tested in a clinical trial, where it helped 20% of patients with glioblastoma live longer, some for as long as three years. ACGT funding will help Dr Fueyo and his research partner, Candelaria Gomez-Manzano, MD, also of MD Anderson Cancer Center, make the virotherapy work for a larger percentage of patients with this brain tumor.

“You cannot sacrifice the organ [the brain]. Gliomas, such as glioblastoma, are not metastatic tumors, meaning they don’t spread far away. They never metastasize. …But since it’s in the brain, it’s more difficult to be cured.” 
—Juan Fueyo, MD, of The University of Texas MD Anderson Cancer Center


Oncolytic virus therapy
is a form of immunotherapy that uses modified versions of viruses to infect and destroy cancer cells. Scientists engineer viruses—such as the herpes simplex virus—to only infect cancer cells, which break apart once they’re infected. The breaking of the cancer cells releases hidden proteins, which can lead to an improved immune response.

ACGT’s mission is to fund research that specifically focuses on cell and gene therapy science. Cell and gene therapy harnesses the power of the immune system to fight cancer. ACGT funds bold and innovative scientists who are researching this field of treatment and advancing it from the laboratories to clinics.

ACGT has awarded 14 grants totaling $6.75 million specifically for projects focused on using cell and gene therapy for brain cancer.

Read the full story about Dr Fueyo’s grant on the ACGT website.

Related Videos
Caspian Oliai, MD, MS, the medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Genovefa (Zenia) Papanicolaou, MD, an infectious diseases specialist at Memorial Sloan Kettering Cancer Center
John DiPersio, MD, PhD, the director of the Center for Gene and Cellular Immunotherapy at Washington University School of Medicine
Aude Chapuis, MD, an associate professor in the Translational Science and Therapeutics Division at Fred Hutch Cancer Center
Amar Kelkar, MD, a stem cell transplantation physician at the Dana-Farber Cancer Institute
David Porter, MD
N. Nora Bennani, MD
Rebecca Epperly, MD, a clinical investigator in the Department of Bone Marrow Transplantation & Cellular Therapy at St. Jude Children’s Research Hospital
John A. Charlson, MD
Judy Lieberman, MD, PhD, the endowed chair in cellular and molecular medicine at Boston Children’s Hospital
© 2024 MJH Life Sciences

All rights reserved.